Skip to main content

Chinese Herbal Medicine (T50) As Add-on To Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus: A 12-week randomized, double-blind, placebo-controlled clinical Trial

Project Member(s): Qu, X., Wallach, M.

Funding or Partner Organisation: Tasly Pharmaceuticals, Inc
Healthpac Centre of Excellence in Intergrative Medicine Pty Ltd (Healthpac)

Start year: 2018

FOR Codes: Endocrinology, Medical and Health Sciences not elsewhere classified, Diabetes, Other health sciences not elsewhere classified, Clinical health